Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Non-Hodgkin Lymphoma, B-Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07429461
What this trial is testing

Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Zhejiang University 16
Not applicableUnknownNCT02987127
What this trial is testing

Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma

Who this might be right for
Mucosa-Associated Lymphoid Tissue Lymphoma
National Taiwan University Hospital 21
Testing effectiveness (Phase 2)Looking for participantsNCT06793410
What this trial is testing

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Who this might be right for
Recipients of Allogeneic Stem Cell TransplantationHPV (Human Papillomavirus)-AssociatedAcute Myeloid Leukaemia+2 more
Vastra Gotaland Region 100
Early research (Phase 1)UnknownNCT05453669
What this trial is testing

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Early research (Phase 1)Active Not RecruitingNCT01695941
What this trial is testing

Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Mantle Cell LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+1 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Looking for participantsNCT06927466
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

Who this might be right for
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. 33
Testing effectiveness (Phase 2)Ended earlyNCT03808610
What this trial is testing

Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent T Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more
M.D. Anderson Cancer Center 53
Early research (Phase 1)WithdrawnNCT02743546
What this trial is testing

Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+1 more
Janssen Research & Development, LLC
Large-scale testing (Phase 3)Study completedNCT01987505
What this trial is testing

MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma

Who this might be right for
Lymphoma, Non Hodgkin
Hoffmann-La Roche 140
Testing effectiveness (Phase 2)UnknownNCT02792491
What this trial is testing

Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over

Who this might be right for
Diffuse Large B-cell Lymphoma
Pusan National University Hospital 57
Testing effectiveness (Phase 2)Study completedNCT01610180
What this trial is testing

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraAutoimmune Thrombocytopenia+2 more
Fondazione Progetto Ematologia 18
Testing effectiveness (Phase 2)UnknownNCT02685670
What this trial is testing

Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+19 more
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20
Testing effectiveness (Phase 2)UnknownNCT03321123
What this trial is testing

MB-CART19.1 in Patients With R/R ALL

Who this might be right for
Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory
Shanghai Children's Medical Center 10
Early research (Phase 1)Active Not RecruitingNCT05618327
What this trial is testing

Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Shanghai Junshi Bioscience Co., Ltd. 104
Testing effectiveness (Phase 2)Looking for participantsNCT06534762
What this trial is testing

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Who this might be right for
NSCLCSCLCColorectal Cancer+4 more
Zhejiang Provincial People's Hospital 260
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Not applicableUnknownNCT04435743
What this trial is testing

Efficacy and Safety of Lenalidomide With or Without Rituximab and Other Drugs in B-cell Non-Hodgkin's Lymphomas

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Ruijin Hospital 1,000
Early research (Phase 1)Study completedNCT03900598
What this trial is testing

JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin
Janssen Research & Development, LLC 226
Early research (Phase 1)Not Yet RecruitingNCT06318884
What this trial is testing

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Sinocelltech Ltd. 76
Early research (Phase 1)Study completedNCT03049449
What this trial is testing

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

Who this might be right for
Lymphoma, Large-Cell, AnaplasticEnteropathy-Associated T-Cell LymphomaLymphoma, Large B-Cell, Diffuse+2 more
National Cancer Institute (NCI) 26
Next Page